Seoul, South Korea · Founded 2021 · Privately Held (backing)
Operator of an artificial intelligence (AI) based new drug development platform intended to discover high-potency drugs. Aigen Sciences is based in Seoul, South Korea and was founded in 2021. It has raised $12 million.
Last price · $/share
—
Implied valuation
—
Total raised
$12.0M
Last round
—
Cap table — not yet on record
Aigen Sciences's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Aigen Sciences with a free account
·The complete investor list: 11 names
·Watch Aigen Sciences: the Monday email on marks, rounds and moves
